美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

The Nightview Fund

26.67

+0.0000

成交量：215.00

成交額：5,699.48

市值：2,250.68萬

市盈率：- -

高：26.67

開：26.67

低：26.67

收：26.67

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

The Nightview Fund

交易所：

ARCA

成立時間：

2018

員工人數：

- -

公司地址：

10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States

官網：

http://www.nightstartx.com

郵編：

73120

電話：

傳真：

405-896-5825

簡介：

Nightstar Therapeutics Plc最初於2013年5月根據英格蘭和威爾士的法律成立，隨後於2014年1月更名為NightstaRx Limited。該公司是一家領先的臨床階段基因治療公司，專註於開發和治療藥物患有罕見的遺傳性視網膜疾病，否則會進入失明。利用他們在眼科，基因治療和藥物開發方面的專業知識，他們正在開發一系列專有產品候選人，旨在大幅度修改或停止目前尚未批準的治療的遺傳性視網膜疾病的進展。他們的任務是維護和通過構建領先的垂直整合視網膜基因治療公司，恢復患者的視力。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NITE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NITE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","market":"US","secType":"STK","nameCN":"The Nightview Fund","latestPrice":26.6742,"timestamp":1745936636709,"preClose":26.6742,"halted":0,"volume":215,"delay":0,"floatShares":843768,"shares":843768,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"04-29 11:50:24 EDT","open":26.6742,"high":26.6742,"low":26.6742,"amount":5699.482730000001,"amplitude":0,"askPrice":26.6,"askSize":1400,"bidPrice":26.57,"bidSize":1400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745956800000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":1506571200000,"exchange":"ARCA","adjPreClose":26.6742,"sharesOutstanding":843768,"nav":26.63,"aum":22472299.01,"bidAskSpread":0,"volumeRatio":0.267657},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NITE\",,,,,undefined,":{"symbol":"NITE","floatShares":843768,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.267657,"shares":843768,"dividePrice":0,"high":26.6742,"amplitude":0,"preClose":26.6742,"low":26.6742,"week52Low":22.21,"pbRate":"--","week52High":31.89,"institutionHeld":0,"latestPrice":26.6742,"eps":0,"divideRate":0,"volume":215,"delay":0,"ttmEps":0,"open":26.6742,"prevYearClose":29.87,"prevWeekClose":26.646,"prevMonthClose":26.3266,"prevQuarterClose":26.3266,"fiveDayClose":24.464,"twentyDayClose":26.3266,"sixtyDayClose":31.38},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1858671235,"yearFounded":2018,"address":"10900 Hefner Pointe Drive,Suite 400,Oklahoma City,Oklahoma,United States","zipCode":"73120","officePhone":"405-778-8377","officeFax":"405-896-5825"},"stockCompanyDetail":{"websiteUrl":"http://www.nightstartx.com","stockEarnings":[{"period":"1week","weight":0.1298},{"period":"1month","weight":0.0108},{"period":"3month","weight":-0.1395},{"period":"6month","weight":-0.0146},{"period":"1year","weight":0.0633},{"period":"ytd","weight":-0.107}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Nightstar Therapeutics Plc最初於2013年5月根據英格蘭和威爾士的法律成立，隨後於2014年1月更名為NightstaRx Limited。該公司是一家領先的臨床階段基因治療公司，專註於開發和治療藥物患有罕見的遺傳性視網膜疾病，否則會進入失明。利用他們在眼科，基因治療和藥物開發方面的專業知識，他們正在開發一系列專有產品候選人，旨在大幅度修改或停止目前尚未批準的治療的遺傳性視網膜疾病的進展。他們的任務是維護和通過構建領先的垂直整合視網膜基因治療公司，恢復患者的視力。","exchange":"ARCA","name":"The Nightview Fund","nameEN":"The Nightview Fund"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NITE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NITE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NITE\",market:\"US\",delay:false,,,undefined,":{}}}